| Reagan-Udall Foundation

Read more about Daiichi Sankyo

Read more about Center for Cancer Research, National Cancer Institute, National Institutes of Health

Read more about Cellectar Biosciences

Read more about Celldex Therapeutics

Read more about Celgene

Read more about Bristol-Myers Squibb

Expanded Access Listings

Expanded Access for Apixaban

This is an expanded access designed to provide access to apixaban for eligibleparticipants.

Read more about Boehringer Ingelheim Pharmaceuticals

Read more about Blueprint Medicines Corporation

Read more about BioXcel Therapeutics

Read more about Biothera Pharmaceuticals, Inc.